# Universal, high-throughput platform for multi-omic analysis of tissue samples with single-cell spatial resolution

> **NIH NIH R41** · SOMAGENE, INC. · 2020 · $400,000

## Abstract

ABSTRACT
The development of technologies for single-cell analysis has strong impact on human health.
Currently, around 1,300 clinical trials are in process to introduce the single-cell analysis in
clinical practice for various types of cancer and infectious diseases. The goal of the proposed
STTR project is the development of a high-throughput transcriptomic platform with multi-omic
potential with spatial resolution at a single-cell and sub-cellular level.

## Key facts

- **NIH application ID:** 10081014
- **Project number:** 1R41CA250833-01A1
- **Recipient organization:** SOMAGENE, INC.
- **Principal Investigator:** Boris Gorbovitski
- **Activity code:** R41 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $400,000
- **Award type:** 1
- **Project period:** 2020-07-01 → 2022-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10081014

## Citation

> US National Institutes of Health, RePORTER application 10081014, Universal, high-throughput platform for multi-omic analysis of tissue samples with single-cell spatial resolution (1R41CA250833-01A1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10081014. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*